#CNIC#ZHAOXIANG#XINLIHECHUANG
Thread about Zhaoxiang et al, team of China national influenza center, one of the authors of first SARSCOV2 genomes in GISAID, evidence of funnelling money into one of his/theirs private company Xinlihechuang(Beijing).1/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 5/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 6/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 7/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 8/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 9/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 10/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 11/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Please be noted: Zhaoxiang made the purchase plan, Zhaoxiang sat on the bidding panel committee to deside who won the bidding, and he chose his own company as winner as always. Here only presented a FEW cases in 2019 12/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
If you wonder how Xinlihechuang connected to Xuwenbo and Maxuejun's company Beijing X-ABT, former as 北京奥科迪医药技术开发有限公司,here is the evidence of key member of XLHC's Liyan. 15/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Another member in CNIC and Xinlihechuang, Lixiaodan. Later joined a Shanghai CDC company-Shanghai Bio-germ, one of the first three companies produced 2019ncov test kits, exclusively recommended by CDC and Tanwenjie, story covered by a report. 16/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
If, ever, Zhaoxiang et al deny his close connection with Shanghai CDC's company and Zhaobaihui, here is a photo of ZX's daughter with ZBH's Son together. 17/n
#CHINACDC
China official coverage about the test kits on 2020-02-03
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 20/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 21/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 22/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 23/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 24/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 25/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 26/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 27/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 28/n
#CNIC#ZHAOXIANG#XINLIHECHUANG
Some previous evidence to demonstrate these are not opportunists, but business person prey on public health for so many years. 29/n
#CNIC#ZHAOXIANG#XINLIHECHUANG If you ever wonder how they 'swing' the open bid towards their own company, pretty easy actually, cooked up three 'different' quotations and lowest bidder wins. Given yourself manipulating the whole process. PAY ATTENTION to the names! 30/n
#CNIC#ZHAOXIANG#XINLIHECHUANG Or, sitting in the reviewed board of the bidding decision to favor your own company. Awkward & shameless? Absolutely No! 31/n
#CNIC#XINLIHECHUANG Here is some of their product manuals, related to flu. Yes, the National flu center sell poor packed, home-brew flu kits to every CDC using materials in their own lab funded by tax payers money. They issued tech guidance for their kits. Sound familiar? 33/n
#CNIC#XINLIHECHUANG Sound familiar? You might want to check with manuals of same products sold by Shanghai Bio-germ🤔 when you can later. 34/n
• • •
Missing some Tweet in this thread? You can try to
force a refresh
An article full of mistakes. 1. A commercial NGS company, Visionmedical, first sequenced and assembled full genome of this bat-like beta coronavirus from sample of a unknown pneumonia patient in Wuhan, before 2020.
2. The 'rectification' was a result of a normal and yearly CNAS biosaftey inspection, btn 3rd-5th Jan 2020, an expert team of 5 did a full inspection, evaluated the emergency response of SHPHCC BSL-3 lab. After inspection, expert team listed 8 issues, suggested rectifications
according to CNAS regulations asap.
In comparison, a CNAS expert team of 4 listed 7 issues and suggested rectifications according to CNAS regulations, in the biosafety inspection in year 2018.
Both above were posted on SHPHCC website news section with timestamp and photos.
Absolutely GOLD to watch the usual participants and media launched campaign again repeating March 2023.
Absolutely shame to use 8 young students' future as human shield to spark this nonsense, nobody actually cares abt these young students, whom weren't even enrolled in 2020.
The snapshots contain rich information. 1. 'it is a novel coronavirus' = distinctive from SARS1, must have been successfully isolated from patient samples, must have been verified (revisit the *chlamydia* in SARS1)
@martinenserink 2. W/o knowing the exact contents, based on the low resolution image and file name of the pptx, predated Virological. That alone, already can be treated as a high confidence evidence that China, through GISAID, was providing a unique additional info regarding the novel cov to WHO
@martinenserink 3. By a glance of the low resolution image of pptx, a possible standard NJ tree of ORF1b. Normally, considering the file size, one page ppt would incl the details of tree creation, against CoV family or particular strains, and *source(s)* of the colour highlighten genomes.
chinaxiv.org/abs/202303.103…
Would love to have a comparison of June 2022 revision and today's new release on ChinaXiv.
If available. So, pls, that 'reviewer who claims to have reviewed the manuscript for Nature'.
I am not caring too much for the conclusion part, as this new version seems targeting for expedited peer-review process. We all see 'toned down' with previous preprints vs publications.
What's important was the comparison of results in those versions.
If the June 2022 vs ChinaXiv, not much difference, and new version get published. Then, I think not CCDC but someone else get explanation to do.
Is it an established fact that no one on twitter or press seem bother emphasising? that: 1. In SAGO meeting, the original data generators said they already *KNEW* the raccoon dogs etc al sequence in the data they produced (before lifted embargo) , and was in the middle of
submitting a revision. 2. The coauthor(obviously not the communication authors with email listed and mobile number too well known to *everyone*) of both preprint and initial illumina data& BGI data, expressed during the initial contact, that(pls pay attention)
*we were told to release the data....feel free to analyse....happy to answer any questions... *.
A brief 'announcement'.😹 Busy with something more important, just break in briefly. 1. Pls, don't want to reply to the DMs flooded in, until we see the origonal data generators' own publication.
2. Accuracy...... If we want to avoid accusations of *power of media*, perhaps anyone point to me the reference of this specific usage implied transferring live animals, 'In one sample from a cart used to move cages', as if the reporter was there...... nature.com/articles/d4158…
3. I *strongly believed* that the original environmental sampling documents and records were written in *Chinese*, no? Why not?
So, if u googled 脱毛机, isn't human epilators all over ur screen? I knew it's hard for some male reviewer #3 to comprehend🤭.